Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy.
Saved in:
| Title: | Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy. |
|---|---|
| Authors: | Wu, Kaixin1,2,3 (AUTHOR) wu_kaixin123@163.com, Li, Sa4,5 (AUTHOR), Hong, Guangliang6 (AUTHOR), Dong, Hongzhi4 (AUTHOR), Tang, Tongke4 (AUTHOR), Liu, He1,2 (AUTHOR), Jin, Lingmei4,5 (AUTHOR), Lin, Siyuan6 (AUTHOR), Ji, Jingyun7 (AUTHOR), Hu, Mingli4,8 (AUTHOR), Chen, Shuntian3 (AUTHOR), Wu, Haoyuan3,4 (AUTHOR), Luo, Guanzheng7 (AUTHOR), Kong, Xiangqian4 (AUTHOR), Chen, Jiekai1,3,4,9 (AUTHOR), He, Jiangping2,6 (AUTHOR) he_jiangping@gzlab.ac.cn, Wu, Hongling4,10 (AUTHOR) wu_hongling@126.com |
| Source: | Clinical & Translational Medicine. Nov2024, Vol. 14 Issue 11, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20011326 |
|---|---|
| DOI: | 10.1002/ctm2.70089 |